Meet the training leader
The pharmaceutical industry is aware that the International Council for Harmonisation is planning to merge the guidelines for Good Clinical Practice (E6) and General Considerations for Clinical Trials (E8). To prepare for this change in 2022 it behoves all clinical trial professions to ensure they are working to the latest expectations when managing their clinical programmes.
Learn how detailed upfront preparation leads to success
Understand the importance of a motivated team with clear priorities
Construct an effective team approach to Quality by Design
Operate a transparent issue management process without micromanagement
Deliver inspection ready clinical trials
In partnership with
Volt Pharma Associates (VPA) is an associate network of world-class BioPharmaceutical consultants and subject matter experts. We help our clients by using our combined experience and industry best practice to design and deliver innovative solutions across the entire biopharmaceutical value chain. Our independent “hands-on” approach helps our clients to release the full potential of their products, organisations & people. We are dedicated to the consistent delivery of successful client outcomes through collaboration, quality assurance, flexibility, cultural alignment, transparency and knowledge sharing.